same tone has been observed in BAL threads something like "China sales only accounts for 6%" so focus on somewhere else if China sales is getting blocked. however the reality is for the time being it is absolutely mandatory to maintain growth in China no matter what. Failing to do so you will see 20x PE for valuation. Youve already seen BAL close to that valuation due to delay of approval. China market is indeed challenging but unfortunately there is no workaround for any IF company.
Chart Update, page-2081
-
- There are more pages in this discussion • 23,328 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.71 |
Change
-0.060(1.04%) |
Mkt cap ! $4.134B | |||
| Open | High | Low | Value | Volume |
| $5.70 | $5.78 | $5.69 | $6.339M | 1.108M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $5.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.72 | 1701 | 2 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |